Prolongation of allograft survival of transfected islets expressing human CTLA4-Ig, human soluble Fas ligand or a combination of the two

Transplant Proc. 1998 Mar;30(2):534. doi: 10.1016/s0041-1345(97)01393-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept
  • Adjuvants, Immunologic / genetics
  • Animals
  • Antigens, CD
  • Antigens, Differentiation / genetics
  • Antigens, Differentiation / immunology*
  • CTLA-4 Antigen
  • Diabetes Mellitus, Experimental / immunology
  • Diabetes Mellitus, Experimental / surgery*
  • Fas Ligand Protein
  • Gene Transfer Techniques
  • Graft Survival / genetics
  • Graft Survival / immunology*
  • Humans
  • Immunoconjugates*
  • Islets of Langerhans / physiology
  • Islets of Langerhans Transplantation*
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Transplantation, Homologous

Substances

  • Adjuvants, Immunologic
  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Ctla4 protein, mouse
  • FASLG protein, human
  • Fas Ligand Protein
  • Fasl protein, mouse
  • Immunoconjugates
  • Membrane Glycoproteins
  • Abatacept